Antithrombotic Usage Indications in Atrial Fibrillation

Akyol A.

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, cilt.27, ss.1-6, 2010 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 27
  • Basım Tarihi: 2010
  • Dergi Adı: TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-6
  • Anahtar Kelimeler: Atrial fibrillation, antithrombotic therapy, stroke, ACUTE ISCHEMIC-STROKE, RHYTHM-CONTROL, EARLY DEATH, SHORT-TERM, RISK, ASPIRIN, WARFARIN, THERAPY, PREVENTION, SEVERITY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, accounting for approximately one-third of hospitalizations for cardiac rhythm disturbances. Stroke is the most important morbidity in AF patients. Antithrombotic therapy is the most effective way to prevent thromboembolic complications of AF. Also, ischemic stroke secondary to AF carry twice the risk of death when compared with strokes from other causes. In this review, we discuss the stroke risk stratification in AF patients and antithrombotic drug usage indication in different clinical situtations according to current published guidelines.